Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2023
22 minute read | November.10.2023

22 minute read | November.10.2023
by Jamie Moore, Daniel Wayte, Patrick Driscoll and Kristy Hart
8 minute read | October.26.2023
by David Rhinesmith, Aaron Brecher and Alison Epperson
5 minute read | October.26.2023
The Department of Justice (DOJ) recently unveiled a policy for voluntary disclosure of misconduct in mergers and acquisitions (M&A).
by Mark Seneca
October.26.2023
by Dr. Lars Mesenbrink
5 minute read | October.19.2023
by Anna Aryankalayil, Craig Falls, Danielle Mangogna, Kristin Petersen and Amy W Ray
3 minute read | October.04.2023
by David M. Ruff, Zac Padgett, Kenneth Rasamny, Andy Bloom and Justin Montis
15 minute read | September.28.2023
The historically illiquid private equity market has found a new path to tradability through the private equity secondaries market/continuation funds.
by Julia Apostle, Alexis Marraud des Grottes and Zac Padgett
9 minute read | September.18.2023
3 hour read | August.08.2023
20 minute read | July.25.2023
by Aria Kashefi, Mark Seneca and John Bautista
May.25.2023
by Harry Clark
2 minute read | May.18.2023